Elisabet Borsheim
Concepts (324)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 14 | 2022 | 170 | 4.340 |
Why?
| Muscle, Skeletal | 23 | 2022 | 847 | 3.890 |
Why?
| Insulin Resistance | 12 | 2022 | 300 | 3.580 |
Why?
| Muscle Proteins | 13 | 2022 | 307 | 2.940 |
Why?
| Exercise | 17 | 2024 | 552 | 2.600 |
Why?
| Insulin | 15 | 2022 | 511 | 1.940 |
Why?
| Mitochondria, Muscle | 5 | 2019 | 46 | 1.890 |
Why?
| Oxygen Consumption | 9 | 2021 | 223 | 1.780 |
Why?
| Pregnant Women | 4 | 2022 | 79 | 1.710 |
Why?
| Diabetes, Gestational | 2 | 2022 | 54 | 1.490 |
Why?
| Dietary Proteins | 3 | 2021 | 230 | 1.380 |
Why?
| Amino Acids | 7 | 2022 | 369 | 1.350 |
Why?
| Blood Glucose | 10 | 2022 | 489 | 1.330 |
Why?
| Energy Metabolism | 11 | 2022 | 311 | 1.320 |
Why?
| Adiposity | 4 | 2024 | 142 | 1.280 |
Why?
| Phenylalanine | 6 | 2022 | 125 | 1.250 |
Why?
| Obesity | 12 | 2024 | 1203 | 1.150 |
Why?
| Amino Acids, Essential | 4 | 2008 | 133 | 1.070 |
Why?
| Triglycerides | 8 | 2022 | 195 | 1.070 |
Why?
| Resistance Training | 3 | 2022 | 102 | 1.060 |
Why?
| Leptin | 2 | 2022 | 154 | 0.970 |
Why?
| Sulfoxides | 2 | 2021 | 28 | 0.960 |
Why?
| Humans | 68 | 2024 | 54391 | 0.960 |
Why?
| Isothiocyanates | 2 | 2021 | 25 | 0.950 |
Why?
| Female | 45 | 2024 | 28471 | 0.950 |
Why?
| Adipose Tissue | 4 | 2019 | 208 | 0.950 |
Why?
| Child | 19 | 2024 | 7368 | 0.930 |
Why?
| NF-E2-Related Factor 2 | 2 | 2021 | 63 | 0.930 |
Why?
| Eating | 2 | 2021 | 163 | 0.920 |
Why?
| Body Mass Index | 9 | 2024 | 712 | 0.920 |
Why?
| Body Composition | 6 | 2022 | 349 | 0.900 |
Why?
| Amino Acids, Branched-Chain | 2 | 2021 | 44 | 0.900 |
Why?
| Pregnancy | 13 | 2024 | 2639 | 0.890 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2020 | 51 | 0.860 |
Why?
| Threonine | 1 | 2022 | 17 | 0.840 |
Why?
| Zinc | 1 | 2022 | 59 | 0.820 |
Why?
| Male | 46 | 2024 | 27347 | 0.810 |
Why?
| Parents | 2 | 2022 | 346 | 0.800 |
Why?
| Child, Preschool | 13 | 2024 | 4158 | 0.790 |
Why?
| Liver | 6 | 2023 | 1226 | 0.790 |
Why?
| Breast Feeding | 2 | 2022 | 191 | 0.790 |
Why?
| Nutrition Policy | 1 | 2021 | 52 | 0.770 |
Why?
| Nutritional Requirements | 1 | 2021 | 69 | 0.770 |
Why?
| Adrenergic beta-Antagonists | 3 | 2014 | 105 | 0.750 |
Why?
| DNA Methylation | 2 | 2022 | 575 | 0.750 |
Why?
| Health Behavior | 1 | 2022 | 275 | 0.710 |
Why?
| Oxidative Stress | 3 | 2021 | 958 | 0.700 |
Why?
| Indocyanine Green | 2 | 2019 | 39 | 0.700 |
Why?
| Blood Cells | 1 | 2019 | 58 | 0.690 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2022 | 486 | 0.680 |
Why?
| Blood Pressure | 2 | 2021 | 587 | 0.680 |
Why?
| Muscle Fibers, Skeletal | 1 | 2019 | 78 | 0.650 |
Why?
| Adipose Tissue, Brown | 5 | 2016 | 45 | 0.640 |
Why?
| Arginine | 4 | 2022 | 182 | 0.610 |
Why?
| Leucine | 5 | 2021 | 113 | 0.580 |
Why?
| Weight Gain | 4 | 2022 | 244 | 0.580 |
Why?
| Adult | 26 | 2021 | 14207 | 0.560 |
Why?
| Hypoglycemic Agents | 2 | 2014 | 177 | 0.540 |
Why?
| Electron Transport Complex II | 1 | 2015 | 11 | 0.530 |
Why?
| Autonomic Nervous System | 1 | 2016 | 75 | 0.530 |
Why?
| Electron Transport Complex I | 1 | 2015 | 42 | 0.520 |
Why?
| Oxidative Phosphorylation | 1 | 2015 | 57 | 0.520 |
Why?
| Adolescent | 14 | 2023 | 6900 | 0.510 |
Why?
| Oxidation-Reduction | 6 | 2021 | 383 | 0.510 |
Why?
| Anabolic Agents | 1 | 2014 | 35 | 0.500 |
Why?
| Androgens | 1 | 2014 | 68 | 0.500 |
Why?
| Dietary Supplements | 7 | 2021 | 457 | 0.480 |
Why?
| Muscles | 1 | 2014 | 114 | 0.480 |
Why?
| Down-Regulation | 1 | 2015 | 388 | 0.470 |
Why?
| Dietary Carbohydrates | 2 | 2004 | 90 | 0.470 |
Why?
| Diphosphonates | 1 | 2014 | 96 | 0.460 |
Why?
| Physical Exertion | 3 | 1998 | 67 | 0.440 |
Why?
| Fatty Acids, Nonesterified | 4 | 2020 | 55 | 0.440 |
Why?
| Cohort Studies | 5 | 2021 | 1546 | 0.430 |
Why?
| Time Factors | 11 | 2020 | 3210 | 0.420 |
Why?
| Aging | 3 | 2015 | 784 | 0.410 |
Why?
| Case-Control Studies | 5 | 2021 | 1229 | 0.400 |
Why?
| Adiponectin | 2 | 2021 | 76 | 0.380 |
Why?
| Homeostasis | 3 | 2021 | 223 | 0.370 |
Why?
| Nitrogen Isotopes | 3 | 2022 | 36 | 0.360 |
Why?
| Glucose Intolerance | 3 | 2020 | 28 | 0.350 |
Why?
| Lipid Metabolism | 3 | 2016 | 194 | 0.350 |
Why?
| Receptors, Adrenergic, beta | 2 | 2000 | 41 | 0.350 |
Why?
| Glucose | 3 | 2023 | 366 | 0.350 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 16 | 0.340 |
Why?
| Muscle Strength | 2 | 2014 | 132 | 0.330 |
Why?
| MicroRNAs | 2 | 2022 | 386 | 0.320 |
Why?
| Fatty Acids | 3 | 2004 | 175 | 0.320 |
Why?
| Palmitic Acid | 2 | 2006 | 25 | 0.300 |
Why?
| Oleic Acid | 1 | 2006 | 7 | 0.290 |
Why?
| Proteins | 1 | 2010 | 376 | 0.290 |
Why?
| Nitrogen | 2 | 2021 | 78 | 0.280 |
Why?
| Animals | 13 | 2023 | 14409 | 0.280 |
Why?
| Lipids | 3 | 2023 | 178 | 0.280 |
Why?
| Carnitine | 2 | 2022 | 86 | 0.260 |
Why?
| Protein Biosynthesis | 4 | 2017 | 273 | 0.260 |
Why?
| Brain Injuries | 1 | 2007 | 184 | 0.260 |
Why?
| Metabolic Diseases | 2 | 2023 | 44 | 0.250 |
Why?
| Renal Dialysis | 2 | 2005 | 193 | 0.250 |
Why?
| Infant | 4 | 2021 | 3829 | 0.250 |
Why?
| Weight Lifting | 1 | 2004 | 31 | 0.240 |
Why?
| Adaptation, Physiological | 2 | 2014 | 103 | 0.240 |
Why?
| Propranolol | 4 | 2014 | 78 | 0.240 |
Why?
| Milk Proteins | 1 | 2004 | 77 | 0.230 |
Why?
| Physical Conditioning, Animal | 1 | 2023 | 59 | 0.230 |
Why?
| Isoflavones | 1 | 2023 | 83 | 0.230 |
Why?
| Mitochondria | 3 | 2016 | 490 | 0.230 |
Why?
| Palmitates | 1 | 2022 | 28 | 0.220 |
Why?
| Fatty Liver | 1 | 2023 | 129 | 0.220 |
Why?
| Lipolysis | 2 | 2012 | 11 | 0.210 |
Why?
| Isoleucine | 1 | 2021 | 27 | 0.210 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2022 | 594 | 0.210 |
Why?
| Aged | 5 | 2022 | 10060 | 0.210 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 133 | 0.210 |
Why?
| Cattle | 1 | 2022 | 225 | 0.200 |
Why?
| Skin Aging | 1 | 2021 | 15 | 0.200 |
Why?
| Glomerular Filtration Rate | 1 | 2021 | 139 | 0.200 |
Why?
| Alanine Transaminase | 1 | 2021 | 151 | 0.200 |
Why?
| Organ Size | 2 | 2019 | 237 | 0.200 |
Why?
| Gestational Age | 2 | 2019 | 435 | 0.190 |
Why?
| Swine | 3 | 2015 | 430 | 0.190 |
Why?
| Milk, Human | 1 | 2021 | 111 | 0.190 |
Why?
| Physical Fitness | 1 | 2020 | 69 | 0.190 |
Why?
| Fibroblast Growth Factors | 1 | 2020 | 60 | 0.180 |
Why?
| Biopsy | 3 | 2014 | 692 | 0.180 |
Why?
| Maternal-Fetal Exchange | 1 | 2020 | 45 | 0.180 |
Why?
| Hydrocortisone | 5 | 2020 | 124 | 0.180 |
Why?
| Meals | 1 | 2020 | 62 | 0.180 |
Why?
| Oxidative Phosphorylation Coupling Factors | 1 | 2019 | 8 | 0.180 |
Why?
| Sarcopenia | 1 | 2020 | 83 | 0.180 |
Why?
| Physical Endurance | 3 | 2004 | 49 | 0.180 |
Why?
| Reproducibility of Results | 3 | 2021 | 1301 | 0.180 |
Why?
| Burn Units | 1 | 2019 | 9 | 0.180 |
Why?
| Schools | 1 | 2020 | 177 | 0.170 |
Why?
| Liver Failure | 1 | 2019 | 27 | 0.170 |
Why?
| Lipoproteins, VLDL | 1 | 1999 | 16 | 0.170 |
Why?
| Young Adult | 7 | 2020 | 4318 | 0.170 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 399 | 0.170 |
Why?
| Adipose Tissue, White | 2 | 2016 | 39 | 0.160 |
Why?
| Models, Biological | 3 | 2019 | 825 | 0.160 |
Why?
| Feeding Behavior | 1 | 2020 | 200 | 0.160 |
Why?
| Monocytes | 1 | 2019 | 156 | 0.160 |
Why?
| Receptors, Adrenergic | 1 | 1998 | 14 | 0.160 |
Why?
| Sympathetic Nervous System | 1 | 1998 | 21 | 0.160 |
Why?
| Cold Temperature | 2 | 2016 | 53 | 0.160 |
Why?
| Ion Channels | 2 | 2015 | 75 | 0.160 |
Why?
| Exercise Therapy | 2 | 2020 | 123 | 0.160 |
Why?
| Cardiovascular Diseases | 1 | 2023 | 476 | 0.160 |
Why?
| Age Factors | 2 | 2019 | 1199 | 0.160 |
Why?
| Arkansas | 2 | 2020 | 2100 | 0.160 |
Why?
| Kinetics | 3 | 2016 | 692 | 0.150 |
Why?
| Hepatocytes | 1 | 2019 | 214 | 0.150 |
Why?
| Heart Rate | 5 | 2007 | 358 | 0.150 |
Why?
| Mitochondrial Proteins | 2 | 2015 | 121 | 0.150 |
Why?
| Blood Platelets | 1 | 2019 | 268 | 0.150 |
Why?
| Urea | 2 | 2010 | 83 | 0.150 |
Why?
| Thermogenesis | 2 | 2014 | 22 | 0.140 |
Why?
| Carbohydrate Metabolism | 1 | 2016 | 31 | 0.140 |
Why?
| Patient Discharge | 1 | 2019 | 353 | 0.140 |
Why?
| Hypertension | 1 | 2021 | 565 | 0.140 |
Why?
| Human Growth Hormone | 2 | 2014 | 51 | 0.140 |
Why?
| Proton Ionophores | 1 | 2015 | 3 | 0.130 |
Why?
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2015 | 5 | 0.130 |
Why?
| Uncoupling Agents | 1 | 2015 | 7 | 0.130 |
Why?
| Oligomycins | 1 | 2015 | 8 | 0.130 |
Why?
| Myofibrils | 1 | 2015 | 21 | 0.130 |
Why?
| Treatment Outcome | 3 | 2014 | 5612 | 0.130 |
Why?
| Deuterium | 3 | 2005 | 41 | 0.130 |
Why?
| Hyperinsulinism | 1 | 2015 | 27 | 0.130 |
Why?
| Carbon Isotopes | 3 | 2005 | 71 | 0.130 |
Why?
| Infusions, Intravenous | 2 | 2013 | 231 | 0.130 |
Why?
| Ethanol | 1 | 1998 | 323 | 0.130 |
Why?
| Nutritional Support | 1 | 2015 | 35 | 0.130 |
Why?
| Oxandrolone | 1 | 2014 | 10 | 0.130 |
Why?
| Body Surface Area | 1 | 2014 | 25 | 0.130 |
Why?
| Quadriceps Muscle | 1 | 2015 | 49 | 0.130 |
Why?
| Ascorbic Acid | 1 | 2014 | 33 | 0.130 |
Why?
| Vitamins | 1 | 2014 | 72 | 0.120 |
Why?
| Placebos | 1 | 2014 | 90 | 0.120 |
Why?
| Cross-Over Studies | 3 | 2020 | 250 | 0.120 |
Why?
| Testosterone | 1 | 2014 | 119 | 0.120 |
Why?
| MAP Kinase Signaling System | 1 | 2014 | 133 | 0.120 |
Why?
| Stress, Physiological | 1 | 2015 | 194 | 0.120 |
Why?
| Predictive Value of Tests | 2 | 2015 | 1045 | 0.120 |
Why?
| Metformin | 1 | 2014 | 66 | 0.120 |
Why?
| Area Under Curve | 2 | 2004 | 205 | 0.120 |
Why?
| Vitamin E | 1 | 2014 | 107 | 0.120 |
Why?
| Signal Transduction | 1 | 2020 | 1752 | 0.110 |
Why?
| Norepinephrine | 3 | 2000 | 119 | 0.110 |
Why?
| Cachexia | 1 | 2013 | 24 | 0.110 |
Why?
| Muscle Strength Dynamometer | 2 | 2014 | 12 | 0.110 |
Why?
| Recombinant Proteins | 1 | 2014 | 570 | 0.110 |
Why?
| Risk Factors | 2 | 2019 | 3937 | 0.110 |
Why?
| Mice | 2 | 2021 | 6428 | 0.110 |
Why?
| Mitochondrial Diseases | 1 | 2014 | 109 | 0.110 |
Why?
| Absorptiometry, Photon | 2 | 2014 | 174 | 0.110 |
Why?
| Fenofibrate | 1 | 2012 | 16 | 0.100 |
Why?
| PPAR alpha | 1 | 2012 | 64 | 0.100 |
Why?
| Rest | 2 | 2014 | 68 | 0.100 |
Why?
| Skin | 1 | 2015 | 469 | 0.100 |
Why?
| Hyperglycemia | 1 | 2012 | 83 | 0.100 |
Why?
| Health Status | 1 | 2013 | 368 | 0.100 |
Why?
| Alanine | 1 | 2010 | 44 | 0.090 |
Why?
| United States | 1 | 2021 | 5208 | 0.090 |
Why?
| Middle Aged | 4 | 2016 | 13082 | 0.090 |
Why?
| Extracellular Fluid | 2 | 2009 | 19 | 0.090 |
Why?
| Anthropometry | 2 | 2024 | 96 | 0.090 |
Why?
| Isoproterenol | 2 | 2000 | 52 | 0.090 |
Why?
| Double-Blind Method | 2 | 2017 | 743 | 0.090 |
Why?
| Hemodilution | 1 | 2009 | 6 | 0.090 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 3 | 0.090 |
Why?
| Isotonic Solutions | 1 | 2009 | 21 | 0.090 |
Why?
| Regional Blood Flow | 2 | 2000 | 121 | 0.080 |
Why?
| Forearm | 1 | 2009 | 41 | 0.080 |
Why?
| Prospective Studies | 1 | 2015 | 2606 | 0.080 |
Why?
| Cholesterol | 1 | 2008 | 155 | 0.080 |
Why?
| Anesthesia, Inhalation | 1 | 2007 | 13 | 0.080 |
Why?
| Isoflurane | 1 | 2007 | 17 | 0.080 |
Why?
| Longitudinal Studies | 2 | 2020 | 742 | 0.080 |
Why?
| Reference Values | 2 | 1998 | 354 | 0.080 |
Why?
| Anesthetics, Inhalation | 1 | 2007 | 35 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2015 | 3431 | 0.080 |
Why?
| Lower Extremity | 1 | 2008 | 103 | 0.070 |
Why?
| Sodium Chloride | 1 | 2007 | 67 | 0.070 |
Why?
| Gait | 1 | 2008 | 98 | 0.070 |
Why?
| Rats | 2 | 2023 | 3419 | 0.070 |
Why?
| Beverages | 1 | 2007 | 83 | 0.070 |
Why?
| Exercise Test | 2 | 2014 | 151 | 0.070 |
Why?
| Epinephrine | 2 | 1998 | 97 | 0.070 |
Why?
| Microdialysis | 1 | 2005 | 21 | 0.070 |
Why?
| Intracellular Fluid | 1 | 2005 | 15 | 0.070 |
Why?
| Carbon Dioxide | 1 | 2006 | 103 | 0.070 |
Why?
| Cell Respiration | 2 | 2016 | 51 | 0.070 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 67 | 0.070 |
Why?
| Creatine | 1 | 2004 | 38 | 0.060 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2005 | 377 | 0.060 |
Why?
| Skiing | 1 | 2004 | 5 | 0.060 |
Why?
| Endocrine System | 1 | 2004 | 12 | 0.060 |
Why?
| Immune System | 1 | 2004 | 49 | 0.060 |
Why?
| Rats, Zucker | 1 | 2023 | 74 | 0.060 |
Why?
| Caseins | 1 | 2023 | 73 | 0.060 |
Why?
| Sex Factors | 2 | 2004 | 766 | 0.060 |
Why?
| Eukaryotic Initiation Factor-2B | 1 | 2003 | 4 | 0.060 |
Why?
| Physical Education and Training | 1 | 2003 | 27 | 0.060 |
Why?
| Catecholamines | 2 | 2004 | 48 | 0.060 |
Why?
| Sports | 1 | 2003 | 52 | 0.050 |
Why?
| Diet | 1 | 2006 | 598 | 0.050 |
Why?
| Soybean Proteins | 1 | 2023 | 153 | 0.050 |
Why?
| Infant, Newborn | 2 | 2020 | 2923 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2021 | 93 | 0.050 |
Why?
| Overweight | 1 | 2023 | 240 | 0.050 |
Why?
| Proteomics | 1 | 2023 | 343 | 0.050 |
Why?
| Hydralazine | 1 | 2000 | 5 | 0.050 |
Why?
| Body Fat Distribution | 1 | 2020 | 11 | 0.050 |
Why?
| Glycerol | 1 | 2000 | 22 | 0.050 |
Why?
| Polysomnography | 1 | 2020 | 71 | 0.050 |
Why?
| Osmolar Concentration | 2 | 2003 | 83 | 0.040 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 1999 | 12 | 0.040 |
Why?
| Language | 1 | 2020 | 137 | 0.040 |
Why?
| Plethysmography | 1 | 2019 | 45 | 0.040 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 137 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 398 | 0.040 |
Why?
| Sleep | 1 | 2020 | 188 | 0.040 |
Why?
| Antioxidants | 1 | 2021 | 297 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2021 | 491 | 0.040 |
Why?
| Adrenergic beta-Agonists | 1 | 1998 | 43 | 0.040 |
Why?
| Bicycling | 1 | 1998 | 43 | 0.040 |
Why?
| Atenolol | 1 | 1998 | 13 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2020 | 208 | 0.040 |
Why?
| Xenon Radioisotopes | 1 | 1998 | 2 | 0.040 |
Why?
| Carbon Radioisotopes | 1 | 1998 | 54 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 807 | 0.040 |
Why?
| Hemoglobins | 2 | 2009 | 126 | 0.040 |
Why?
| Inflammation | 1 | 2021 | 678 | 0.040 |
Why?
| Lipoproteins | 1 | 2016 | 45 | 0.040 |
Why?
| Mice, Inbred C57BL | 1 | 2021 | 2001 | 0.030 |
Why?
| Neck | 1 | 2016 | 116 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2016 | 370 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 308 | 0.030 |
Why?
| Isometric Contraction | 1 | 2014 | 25 | 0.030 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 19 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 55 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 55 | 0.030 |
Why?
| Torque | 1 | 2014 | 24 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2014 | 19 | 0.030 |
Why?
| Calorimetry, Indirect | 1 | 2014 | 29 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2014 | 67 | 0.030 |
Why?
| Basal Metabolism | 1 | 2014 | 36 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 643 | 0.030 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 99 | 0.030 |
Why?
| Demography | 1 | 2014 | 103 | 0.030 |
Why?
| Prognosis | 1 | 2019 | 2126 | 0.030 |
Why?
| Survivors | 1 | 2014 | 137 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2019 | 2390 | 0.030 |
Why?
| Recovery of Function | 1 | 2014 | 222 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2020 | 1616 | 0.030 |
Why?
| Radiopharmaceuticals | 1 | 2014 | 242 | 0.030 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2014 | 212 | 0.030 |
Why?
| Ambulatory Care | 1 | 2014 | 231 | 0.030 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 16 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2014 | 323 | 0.030 |
Why?
| Hypolipidemic Agents | 1 | 2012 | 33 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2014 | 1082 | 0.020 |
Why?
| Plasma Volume | 1 | 2009 | 9 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 40 | 0.020 |
Why?
| Radial Artery | 1 | 2009 | 38 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 178 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 1222 | 0.020 |
Why?
| Veins | 1 | 2009 | 74 | 0.020 |
Why?
| Population | 1 | 2007 | 10 | 0.020 |
Why?
| Cardiac Output | 1 | 2007 | 50 | 0.020 |
Why?
| Hormones | 1 | 2007 | 59 | 0.020 |
Why?
| Coloring Agents | 1 | 2007 | 84 | 0.020 |
Why?
| Methods | 1 | 2005 | 66 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 8 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 63 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 214 | 0.020 |
Why?
| Fluorocarbons | 1 | 2005 | 52 | 0.020 |
Why?
| Body Weight | 1 | 2007 | 578 | 0.020 |
Why?
| Rabbits | 1 | 2005 | 425 | 0.020 |
Why?
| Granulocytes | 1 | 2004 | 27 | 0.020 |
Why?
| Albumins | 1 | 2004 | 39 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2004 | 61 | 0.010 |
Why?
| Leg | 1 | 2003 | 130 | 0.010 |
Why?
|
|
Borsheim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|